Lee-Hou Tsai1, Meng-Chih Lee2
1 Department of Psychiatry, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan.
2 Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan.
Tsai LH, Lee MC / Arch Clin Psychiatry. 2016;43(6):157-8
Received: 7/5/2016 – Accepted: 11/10/2016
Address for correspondence: Lee-Hou Tsai. E-mail: firstname.lastname@example.org
The World Health Organization classifies depression as one of the top three diseases of the 21st century, along with cardiovascular disease and cancer. Depression is a mental illness that requires significant attention in elderly patients1. Symptoms of major depression, internal and surgical drug-induced factors, and the use of antidepressants and their side effects need to be monitored in elderly patients.
We examined the effects of antidepressant discontinuation in a 69-year-old woman with psychotic symptoms and depression. The subject provided informed consent, and patient anonymity was preserved. The patient’s history, physical and neurological examination results, family history, and laboratory data were used in the diagnosis. Figure 1 shows the patient’s hospital course.
The onset of symptoms was distinct and notable. These symptoms indicated a diagnosis of major depressive disorder with psychotic symptoms, together with multiple discomforts, mood-congruent delusion of being abducted, and a family history of depression2,3. The patient also had delirium based on the reduced awareness of her environment, disorientation, and perceptual disturbances that developed over a short period and fluctuated during the day, according to the criteria of the Confusion Assessment Method4.
The delirium caused by the discontinuation of paroxetine was treated with low-dose quetiapine, which had less anticholinergic and rare extrapyramidal side effects, as hallucinations can be induced by paroxetine discontinuation in middle-aged women5. Similarly, the present case study shows that sudden discontinuation of long-term antidepressants can trigger psychosis. The severity of withdrawal from selective serotonin reuptake inhibitors appears to vary according to the half-life of the drug; that is, the shorter the half-life, the worse the discontinuation effects6,7.
The patient’s antidepressant discontinuation syndrome (ADS) manifested flu-like symptoms, sensory disturbances, and hyperarousal. ADS can be rapidly extinguished by early reinstitution of non-anticholinergic antidepressant (e.g., citalopram)8. Although ADS is not life threatening, it can be distressing to the patient because it can be easily mistaken for symptoms of returning depression6,7. For elderly patients, ADS may continue for longer periods with more severe symptoms.
We report that the non-anticholinergic effects of citalopram and similar drugs such as escitalopram can significantly improve cognitive function in elderly patients with depression. Antidepressants with non-anticholinergic side effects can shorten hospitalization duration in patients with depression and allow them to return to the community earlier.
Conflict of interests
No conflict of interests are reported.
- Luchesi BM, Degani GC, Brígola AG, Pavarini SCI, Marques S. Evaluation of depressive symptoms in older caregivers. Arch Clin Psychiatry. 2015;42(2):45-51.
- Hwang JP. Textbook of Clinical Geriatric Psychiatry. Taipei: Ho-Chi Book Publishing; 2011. Chapters 5-7.
- Sadock BJ, Sadock VA. Kaplan & Sadock’s Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Philadelphia (PA): Lippincott Williams & Wilkins; 2007. Chapters 5-6.
- Dening T, Thomas A, editors. Oxford Textbook of Old Age Psychiatry. Oxford: Oxford University Press; 2008. Chapter 28.
- Yasui-Furukori N, Kaneko S. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders. Psychiatry Clin Neurosci. 2011;65(4):384-5.
- Marken PA, Munro JS. Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features. Prim Care Companion J Clin Psychiatry. 2000;2(6):205-10.
- PubMed Central [Internet]. Bethesda MD: National Institutes of Health’s National Library of Medicine (NIH/NLM). 2016. Available from: http://www.ncbi.nlm.nih.gov/pmc/.
- Warner CH, Bobo W, Warner C, Reid S, Rachal J. Antidepressant discontinuation syndrome. Am Fam Physician. 2006;74(3):449-56.